UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,009,525 | -39.7% | 297,267 | +0.2% | 0.00% | -40.0% |
| Q2 2023 | $3,330,298 | -41.0% | 296,818 | +5.0% | 0.01% | -37.5% |
| Q1 2023 | $5,640,456 | -11.8% | 282,588 | -0.7% | 0.01% | -20.0% |
| Q4 2022 | $6,393,104 | +23.7% | 284,644 | +2.5% | 0.01% | +25.0% |
| Q3 2022 | $5,167,000 | +2.3% | 277,668 | -0.3% | 0.01% | +14.3% |
| Q2 2022 | $5,052,000 | -0.2% | 278,526 | +0.8% | 0.01% | +16.7% |
| Q1 2022 | $5,060,000 | -13.7% | 276,375 | +1.3% | 0.01% | -14.3% |
| Q4 2021 | $5,863,000 | -34.2% | 272,781 | -1.5% | 0.01% | -41.7% |
| Q3 2021 | $8,912,000 | +28.3% | 276,931 | +22.8% | 0.01% | +33.3% |
| Q2 2021 | $6,944,000 | – | 225,467 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |